Follow us on

Q of the week

Q: Do clinical trials ever go wrong?

Get the Answer: 

Prototype devices

It is recognized that a manufacturer may wish to submit a small number  of "prototype models" of a device to clinical investigation in order to assess safety and/or performance; and those such prototypes may need to undergo a number of changes prior to large-scale production.

Welcome Guest   [Register]  [Login]
EFGCP–EUCROF Joint Workshop Final Report   by  on 2010-08-20 12:12:20
Managing Clinical Trials   by  on 2010-07-15 16:05:32
US-FDA issues Revised Info Sheet Guidance on Clinical Investigator Disqualification   by  on 2010-06-13 10:11:41
US-FDA issues final guidance on Statement of Investigator (Form FDA 1572)   by  on 2010-06-13 10:07:59
Rising Clinical Trial Complexity Continues to Vex Drug Developers   by  on 2010-06-03 09:36:33
Investigator-Driven Clinical Trials: An ESF Forward Look   by  on 2010-06-03 09:27:58
NIH's Financial Conflict of Interest (FCOI) Proposed Rule   by  on 2010-05-27 11:42:00
AAP’s Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Population   by  on 2010-05-13 11:39:54
Argentina: ANMAT - new regulatory update   by  on 2010-05-01 01:40:32
The Wall Street Journal's special supplement on clinical trials   by  on 2010-05-01 01:31:52
Major developments in EU Clinical Trial Guidances   by  on 2010-04-20 19:10:55
Analysis of the adverse reactions induced by natural product-derived drugs   by  on 2010-04-18 23:16:06
Newer Antibacterial Drugs for a New Century   by  on 2010-04-18 22:49:47
Newer Non-Statin Drugs for Reducing Cholesterol   by  on 2010-04-13 07:57:20
Practice Guidelines for Chronic Pain Management   by  on 2010-04-04 20:52:16
CONSORT III (2010)   by  on 2010-03-29 12:53:28
US FDA Draft Guidance on Pharmacokinetics in Patients with Impaired Renal Function   by  on 2010-03-20 12:25:16
US-FDA issues First Draft Guidance on Noninferiority Trials   by  on 2010-03-04 14:07:46
US FDA new rule on reporting information regarding falsification of data   by  on 2010-02-25 20:47:33
US-FDA Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials   by  on 2010-02-06 12:12:14
 Subject :Thailand joins the PCT as 142nd Country.. 2010-01-11 16:54:48 
Joined: 2009-09-18 20:04:52
Posts: 16

On 24 September 2009, Thailand became the 142nd country to ratify the Patent Cooperation Treaty ("PCT").

Full Update

The PCT is an international agreement which enables multinational patent protection via a single application. It is open to contracting states of the Paris Convention for the Protection of Industrial Property, which Thailand joined in August 2008. Thailand's membership takes effect on 24 December 2009.

Principal benefits of the PCT:

  1. Inventors need only file one international patent application at the Department of Intellectual Property in their home country to acquire patent protection simultaneously in other PCT member countries.
  2. Costs will be significantly reduced as only one application needs to be submitted.
  3. Applicants have the opportunity to conduct an international patent database search and carry out an international preliminary examination to evaluate the chances of success in acquiring patent protection in a particular country. Applicants may amend or suspend any applications where it appears that there is little chance of success.
  4. The process of obtaining an international patent via the PCT system is significantly faster and simpler.
  5. Obtaining international protection through the PCT puts a patent in the world arena, and thus serves as a valuable advertising tool.
  6. Third parties are able to develop sound opinions in relation to an invention's patentability.
  7. To facilitate Thailand's membership of the PCT, the Ministerial Regulation No. 21 B.E. 2542 (1999) will need to be revised, particularly to reflect the Thai Patent Office's role as a Receiving Office under the PCT system, as well as the fees for international patent applications.

Kind regards,



IP Logged
Page # 

Powered by ccBoard